Photo

Photo detail

Stories this photo appears in:

MemorialCare Foundation Folds in 4 Doctors Groups

Interest in Endologix Could Bring Premium Price; Conifer Picks Anaheim for Consolidation

Memorial Care Health System in Fountain Valley has added four doctors groups to its foundation, in the Healthcare column

Tease photo

Key Congressman Set to Probe Medical Device Costs

Tenet Bucks Investor Cheer on Takeover Bid; Dentists Reach for Help on Business Services

A Republican congressman who will head an investigating committee in the House aims to cut medical costs for government-sponsored programs, in the Healthcare column

FDA Fees Get Mixed Review from Drug, Device Makers

Orange Coast Memorial Adds Eye Center; Quality Systems Adds Former TriZetto Executive

A recent survey that polled 50 drug makers indicates mixed feelings about the effectiveness of FDA user fees, in the Healthcare column

Apria’s November Worth the Wait for Medicaid Wins

‘Happy Ending’ Seen on Endologix Buy; Mild Progress for Vertos; Grubb & Ellis in Carolina

Lake Forest-based Apria Healthcare recently won several Medicaid contracts, in the Healthcare column

Rivals Seek Deals To Catch Edwards

Website Vets Medicare Plans; Local Cos. Give for Santa Ana Center

Rivals of Irvine's Edwards Lifesciences are looking at ways to catch up with the device maker on its less-invasive heart valve, in the Healthcare column

Tease photo

Mazzo, AdvaMed Back to Japan for Regulatory Push

Quality Systems Software Could Help on Stimulus Money; Watson Misses on Bladder Drug

Jim Mazzo recently met with Japanese officials in his duties as chairman of a medical device trade group, in the Healthcare column

Tease photo

Elections May Cause Problems For Insurance Industry

Bausch & Lomb Hires in its Surgical Unit; Fullerton Medical Condos Sell For $1.5 Million

The midterm elections could affect health insurance stocks and cause problems for health reform, in the Healthcare column

Herbert Makes Another Gift to Namesake Eye Institute

Alliance HealthCare Sees Tough Q3; Anaheim General Hospital Regains Medicare Eligibility

Gavin Herbert has made another sizeable donation to UC Irvine’s proposed Gavin Herbert Eye Institute, in the Healthcare column

Tease photo

Early Europe Approvals for Medical Devices Could Fade

Device Maker Raises $4.7M, UCI Medical Center Adopts New Name, Honors Donor Douglas

Regulators in the U.S., Japan and Europe are looking to unify their approval process for medical drugs and devices, which could make approvals tougher in Europe, in the Healthcare column

Report: Hospital Purchasing Groups More Expensive

Progress on New Use for Ista’s Bepreve; UCI Event Looks at Potential of Wireless Healthcare

A medical device trade group headed by Masimo Chief Executive Joe Kiani is taking aim at hospital buying groups, in the Healthcare column

Tease photo

Mazzo Visits Beijing, Pushes Agenda for Trade Group

UCI Researcher Gets Grant to Study Staph Infections; Cortex Takes Back Ampakine Compound

James Mazzo visited China on behalf of medical device trade group Advamed, in the Healthcare column

Tease photo

Valeant Deal Wraps Up, But Not Before Parting Shots

Allergan Seeks Broader Use of Lap-Band Obesity Device, Sees Eye Implant Use Expanded

Valeant’s sale to Canada’s Biovail is a done deal, in the Healthcare column.

Tease photo

Investor Websites Take Note of Sun Healthcare’s Split

UCI Researchers: Fruit Fly Analysis Yields Broader Insight; CardiAQ Unveils Valve Results

Investor websites are taking notice as Sun Healthcare prepares to split itself into two separate companies, in the Healthcare column

Allergan, Generic Rival Apotex Tussle Again with Suit

Healthcare Payment Processor InstaMed Raises $6 Million; Medtronic Gets Catheter Clearance

Allergan is battling a Canadian drug maker over a generic version of one of its drugs, in the Healthcare column

Report: Demand, Revenue Rising for Device Makers

Sun Healthcare Repaying Some Debt Before Spin-off, Planning Another Debt Offering Soon

The medical device industry will see a big boost in sales as people live longer, in the Healthcare column

Allergan Reworks Development Deal for Dry Eye Drug

UC Irvine Researchers See Positive Stem Cell Test Results; Apria Grows in Kansas City Area

Allergan has reworked a deal that will allow it to switch its focus on a dry eye treatment, in the Healthcare column

Tease photo

Blogger: Allergan Has Growth, Acquisition Potential

ICU Medical’s Latest Connector Designed To Address Regulatory Concerns About Infections

Allergan has a fan at investor website Seeking Alpha, in the Healthcare column

Tease photo

Employers May Focus More on Wellness To Curb Costs

Tenet Sees Drop in Admissions with Fewer Baby Deliveries; Healthcare Fund Buys in Idaho

Controlling costs brought on by healthcare reform might fall to employers, in the Healthcare column

Tease photo

Cancer Testing Company Clarient Swings to Q2 Profit

UCI-Developed Stem Cell Trial Resumes; Okapi Portfolio Company Sold for $105 Million

Aliso Viejo’s Clarient saw second-quarter results that beat Wall Street’s expectations, in the Healthcare column

Analyst: UnitedHealthcare To Survive, Thrive on Reform-++

Masimo, Hygia Reach Undisclosed Settlement On Labeling, Patent Infringement Lawsuit

United Healthcare stands to benefit from the recently enacted healthcare reform bill, in the Healthcare column

Tease photo

Survey: Healthcare Investors Expect Increase in M&A

Allergan Sees Generic Challenge for Latisse Drug, Not Likely To Hit Market Any Time Soon

Merger and acquisition activity for healthcare companies is on the rise in OC, in the Healthcare column

Tease photo

Healthcare Waste Fighter AMG-SIU Selling for $26M

Surgery Centers Fighting Proposed Cut in State Funding; Allergan’s Ingram Gets New Position

AMG-SIU is getting a new owner, in the Healthcare column

Analyst: Beckman Heart Test Troubles Start To Fade

Grubb & Ellis Buys in Cleveland, Texas; Former Allergan Exec Now President of Florida Co.

Things are looking up for Beckman Coulter after the medical testing company dealt with a recall earlier this year, in the Healthcare column

Valeant Buyout Solves Growth Issue for Drug Maker

French Artificial Heart Maker with Edwards Tie Going Public; Hoag Expanding Sleep Center

Valeant Pharmaceutical’s acquisition is set to benefit the drug maker in the long run, in the Healthcare column

Tease photo

Beckman Rises as Rival Takes Hit on Outlook Revision

Clinical Convention Comes to Anaheim; Moody’s Upgrades Tenet Healthcare, Still Cautious

Beckman Coulter’s shares rise as a rival feels the wrath of Wall Street, in the Healthcare column

Medtronic Near U.S. Trial of Less-Invasive Heart Valve

Drug Maker with UCI Ties Gets Foundation Money; Private Equity Could Turn To Healthcare

A medical device maker with operations in OC could be close to starting clinical trials for its less-invasive heart valve, in the Healthcare column

Irvine’s Prescription Solutions Expects To Double in Size

Heart Valve Maker Moves HQ to Irvine; UC Irvine Researchers Make Retina from Stem Cells

Job growth at Prescription Solutions exceeds expectations, in the Healthcare column

Teva To Quit Selling, Making Propofol at Irvine Plant

Smile Brands Officially Drops IPO Plans; Edwards Heart Valve Shows Good Survival Rate

Drug maker Teva Pharmaceutical is stopping production of a drug made in Irvine, in the Healthcare column

Tease photo

Beckman to Run New Clinical Trial Early Next Year

Children’s Hospital of OC Looks to Raise $125M by 2013; FDA Clears Allergan Eye Drug

Beckman Coulter plans a clinical trial after making changes to a heart disease test, in the Healthcare column

Tease photo

Allergan Stands to Profit from Boomer Vanity Spending

Doctors’ Group Talbert Medical Bought; Healthcare Software Maker Enclarity Gets Funding

Allergan could benefit from an aging population spending on its looks, in the Healthcare column

Ensign Group Buys 3 Facilities, Looks for Opportunities

Valeant, Partner Get Canadian Approval for Cancer Drug; Masimo Starts Nonprofit Foundation

Ensign Group is making good on its promise to buy more facilities, in the Healthcare column

Seal Beach Plant To Produce Recently Approved Drug

Teva Warned Over Sedation Drug Made in Irvine; Edwards Prevails in Germany Patent Case

Seal Beach is set to play a key role in making a highly touted biotechnology drug come 2011, in the Healthcare column

Tease photo

Former Integrated President Center of Hospital Drama

Chapman Medical Opens Spine and Neurology Center; UCI Hosts Healthcare Reform Talk

A former president of Integrated Healthcare has beaten back an attempt to oust him from his current job, in the Healthcare column

Analyst: Medicare Advantage Insurers to Raise Rates

Grubb Buys $17.4M in Medical Offices; Fitch ‘Neutral’ on Reform’s Effect on Some Hospitals

One analyst says health insurance companies such as UnitedHealth Group soon will cut benefits and raise premiums, in the Healthcare column

Analyst: $20B Tax to Stir M&A, Increase Hospital Costs

Report: Electronic Medical Records No Panacea; ChromaDex Purchases Rights to Compound

Some smaller medical device makers are worried about the effects of a $20 billion, 10-year tax on the industry, in the Healthcare column

Tease photo

Allergan Strikes Up Drug Deal as Part of Urology Push

Watson Seen Benefiting from Medicare Drug Gap Plug; Testing Company Hycor Gets CEO

Allergan is adding to its drugs for treating urinary disorders, in the Healthcare column

Apria, Others Take on Medicare Competitive Bidding

Eye Device, Drug Makers, Investors Meet; Cortex Sells Compounds, Patents for up to $25M

A home healthcare trade group is taking on the Centers for Medicare and Medicaid Services, in the Healthcare column by Vita Reed

Valeant Acquires in Brazil, Analyst Sees More Deals

Vertos Reports Results on Study of Spinal Device; Grubb Buys Medical Space in New Orleans

Valeant Pharmaceuticals International is continuing its global shopping, in the Healthcare column by Vita Reed

Analyst: Spectrum Pharmaceuticals “Underappreciated”

Report: TriZetto Behind Payment Snag in Wisconsin; Abbott’s Tecnis Lens Approved by FDA

Spectrum Pharmaceuticals recently got a nod from an analyst as an “underappreciated” stock, in the Healthcare column by Vita Reed

Mussallem Turns Over Trade Group Reins to Mazzo

Edwards’ UCI Presentation Changes Analyst’s Mind on Taxing Devices for Healthcare Reform

AdvaMed again has tapped an OC medical device executive as its leader, in the Healthcare column by Vita Reed

Analyst: Doctors ‘Encouraged’ by New Heart Valves

Grubb & Ellis Buys Medical Office Building; Former OC Device Maker Gets FDA Warning

Less-invasive replacement heart valves from Edwards and rival Medtronic got a thumbs-up late last month from an analyst, in the Healthcare column by Vita Reed

Report: Cost Cutting Top Healthcare Industry Concern

Avanir’s Zenvia Has Promising Third-Phase Trial; FDA Clears Agendia’s Breast Cancer Test

Cutting costs will be the “overarching theme” for the healthcare industry in 2010, a report says, in the Healthcare column by Vita Reed

Tease photo

Synovis Expands on Pegasus Buy, Hires 25 in Irvine

Edwards Enrolls Patients for Sapien Trial, Completes Sale of Product Line to Former Parent

Minnesota’s Synovis is rebuilding a medical products business in Irvine, in the Healthcare column

Tease photo

Journal: Valeant’s Performance-Based Pay Sets Example

Sybron Doing More Than Settling Lawsuits; Quality Systems To Use Atlanta Co.’s Software

Valeant is praised for its performance-based executive pay structure, in the Healthcare column

Tease photo

Japanese Eye Drug Maker Opens Office Near Airport

Edwards Lifesciences Offered $11M to Keep Jobs in Utah; BioLase Gets OK to Sell in China

A Japanese drug maker opens an Irvine office, in the Healthcare column

Tease photo

Survey: Most Hospitals Can’t Finance Seismic Retrofits

ICU Medical Cutting Back on R&D Spending; Cortex Pharmaceuticals Gets $2M Investment

Tight construction financing is hitting hospitals, in the Healthcare column

Tease photo